# NOREPINEPHRINE BITARTRATE

NDC: 0338-0112
Generic name: norepinephrine bitartrate
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210115

FDA application: NDA214313

## Active ingredients

- NOREPINEPHRINE BITARTRATE: 4 mg/250mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0112"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0112
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6363e9b4-29df-4553-904d-a563e5adda6e